Login
Close
search

Search

Most Popular
Search Box
Healthcare Marketing

Certificate

Mini-MBA in Drug Commercialization & Product Strategy

Your Play Book to the Drug Commercialization Process

With a focus on disease prevention, customized treatments, digital therapeutics, and the ripple effects of COVID-19 on healthcare, the pharma industry is changing at lightning speed. Pharma professionals need to navigate both the regulatory and business realities of the drug commercialization process and bridge the gap between scientific innovation and business goals in order to lead successful go-to-market strategies.

OpusVi™ and the University of Arizona’s Eller Executive Education have created the Mini-MBA in Drug Commercialization & Product Strategy to help you develop an understanding of pharmaceutical product development, commercialization, and regulations as well as the business and management skills that you need to master the drug commercialization process from bench to bedside.

Three

leading pharma experts inform the program from start to finish to ensure relevancy and applicability

Twelve

weeks of learning content teach key concepts from commercialization, positioning and forecasting, manufacturing and distribution, to timing strategies

Five

academic specialists from the University of Arizona’s Eller Executive Education, James E. Rogers College of Law, and Eller College of Management develop and present high-quality learning content

Two

Olympic gold medalists give insights into performing and persevering, even under pressure

Mini-MBA in Drug Commercialization & Product Strategy

Mini-MBA in Drug Commercialization & Product Strategy

  • pdf
Download

Program Outline

With ever-changing market forces, political climates, and regulatory changes, pharmaceutical business leaders are expected to do more with less, work easily across functions, and to always be ready for change. From drug discovery through end-of-patent life, the Mini-MBA in Drug Commercialization & Product Strategy program exposes students to critical business, scientific, and regulatory challenges that leaders face at all stages of a product’s commercialization. Our 100% online, cohort-based program is taught by leading experts in pharmaceuticals, law, and business, and provides opportunities for learners to build practical, real-world knowledge that can be applied to their jobs right away.

Pre-launch

  • Week 1: Overview of the Product Pharma Landscape and Commercialization
  • Week 2: Drug Development and Regulation
  • Week 3: Positioning and Forecasting
  • Week 4: Market Access and Market Research

Launch

  • Week 5: Market Access and Project Management at Launch
  • Week 6: Optimizing Manufacturing and Distribution
  • Week 7: Communication at Launch and the Flow of Money
  • Week 8: Legal Aspects of Commercialization and Market Access Roll Out

Maturity and End-of-patent

  • Week 9: Brand Lifecycle and Market Expansion
  • Week 10: Life Cycle Management Timing Strategies
  • Week 11: Strategic Alliances and Strong Lifecycle Management Strategies
  • Week 12: Putting It All Together: Capstone Project

This course is designed for all levels of learners looking to build or enhance their career in the pharmaceutical industry. Among other things, you will learn to:

  • Develop a comprehensive understanding of the drug development and commercialization process from drug discovery through the end-of-patent life
  • Identify the differences and strategic needs brands face as they transition through pre-launch, launch, early in-market, growth, maturity, and end-of-patent life phases of a brand’s lifecycle
  • Obtain strategic insights into the broad range of functional area engagement with pharmaceutical commercialization and brand management, including:
    • General business strategy
    • Market access
    • Pharmaceutical science
    • Legal environment/regulatory needs 
    • Marketing
    • Market research
    • Finance
    • Operations management
  • Recognize the multifunctional needs and interdependency of the critical skills and disciplines required for successful pharmaceutical commercialization
  • Synthesize key insights and obtain an understanding of managed care/market access needs at all stages of the pharmaceutical commercialization process
  • Develop self-awareness and leadership skills to influence others and to achieve greatness

This certificate program is ideal for professionals in the pharmaceutical industry or related industries who wish to develop a cross-disciplinary understanding of the drug development process and gain new leadership skills to accelerate growth in the business. This comprehensive understanding of the drug development and commercialization stages will help build better relationships between departments and outside the organization to be successful.   

Learners who will benefit most from our Mini-MBA in Drug Commercialization & Product Strategy are:

  • Late entry to mid-level managers within pharma looking to transition into more senior roles
  • Professionals who are in pharma but currently siloed and who are looking to move about the organization, for example by switching their core focus from marketing to operations, finance to marketing, etc.
  • Professionals looking to enter the pharmaceutical industry who have a good understanding of business but lack pharma industry knowledge
  • Professionals who want to perform better in their current role by gaining a better understanding of financial operations, trend analysis, forecasting, financial statements, and more in a pharma business context

Don’t see yourself in the above-mentioned roles? We recommend that you inquire with us to discuss your unique situation with your dedicated Enrollment Advisor.

We don’t recommend this program for pharmacy managers. If you’re interested in learning more about managing healthcare-related businesses, inquire about our 12-week Mini-MBA in Healthcare or our online MBA in Healthcare degree instead.

Highly Relevant and Actionable Learning Content

With a focus on real-world application, our Mini-MBA in Drug Commercialization & Product Strategy has been created with industry experts who know what it takes to navigate the competition and reach your own professional goals.

The learning content is 100% online and designed for remote learning

Accessible

The learning content is 100% online and designed for remote learning

Multimedia learning experience includes videos, self- reflective exercises, and highly-relevant case studies

Engaging

Multimedia learning experience includes videos, self- reflective exercises, and highly-relevant case studies

Study in a cohort of pharma professionals and get feedback from expert instructors

Social

Study in a cohort of pharma professionals and get feedback from expert instructors

Our learning content is customized to product pharma development and commercialization

Focused

Our learning content is customized to product pharma development and commercialization

Capstone project concluding the program prepares you to put your plans into action under the guidance of an expert instructor

Actionable

Capstone project concluding the program prepares you to put your plans into action under the guidance of an expert instructor

DHGE wins two Hermes Creative Awards for Website Redesign and our Educational Video

Learn to Win in Business

In an innovative approach, our curriculum features two Olympic medal winners: three-time Olympic gold medalist, 13-time World Indoor and Outdoor medalist, and world record holder Gail Devers; and one-time Olympic gold medalist, three-time world champion, and world record holder Dan O’Brien. These professional athletes bring their unique perspectives to achieving greatness on the job, overcoming setbacks while pursuing perfection, and performing under pressure.

Meet Your Success Coaches — Made With

Olympic Gold Medalists

Get Insights on Overcoming Adversity

Not only is the pharma industry highly competitive, it is also highly regulated. As a result, many drugs and treatments never make it to the bedside. How can pharma leaders optimize their chances and lead a successful drug commercialization process — or keep their courage if a product has failed to make it to the bedside?

Learn more about overcoming setbacks from our Olympic success coaches: Dan O’Brien was competing for the title of the World’s Greatest Athlete in the now infamous Dan & Dave Reebok advertising campaign when he failed to qualify for the 1992 Olympics. While about to reach the peak of her career as a track and field athlete, Gail Devers developed Grave’s Disease, an autoimmune disease that, ultimately, left her at the risk of getting her feet amputated. Both Dan and Gail had to overcome obstacles in order to win Olympic gold medals — now, they are sharing their insights on facing adversity in our Mini-MBA in Drug Commercialization & Product Strategy.

Gail and Dan’s motivational contributions are integrated into condensed, research-based learning content of an MBA-level that is developed and presented by academic experts from the University of Arizona’s Eller Executive Education, Eller College of Management, and James E. Rogers College of Law — so you can gain a pharma-specific business foundation in a short time without sacrificing depth.

Gail Devers

Gail Devers

Three-time Olympic gold medalist, 13-time World Indoor and Outdoor medalist, and world record holder

You can have all the potential in the world, but if you don't have the mindset to take the pitfalls, the ups and the downs, you're not going to make it. I had to keep myself in that mode, that I can do whatever I have to do. For me, that comes from setting a goal. When I set my goals, I write them down and I sign them. People ask me, “Why do you sign it?” Because word is bond. And when I sign it, that's that commitment I have to do whatever, however long it takes to accomplish what I want to accomplish.

Dan O’Brien

Dan O’Brien

One-time Olympic gold medalist, three-time world champion, and world record holder

As an Olympic athlete, I have inspired a lot of people and that's infectious. If my efforts as an Olympic athlete, and my examples on overcoming adversity and setting goals can inspire somebody out there to go to the next level — those are the things that give me the most joy. Those are the things that give me a reason to wake up in the morning and continue to do my job great each and every day.

Alyssa Foster, MA, COC

Alyssa Foster, MA, COC

Owner of Directive Strategy Group and Co-Founder of 4Front Strategic Partners

Well-intended drug developers sometimes find themselves too far along the development process before considering all aspects that are required to make a product successful. There is nothing more disappointing to a patient who has waited years for a new therapy than facing access barriers after FDA approval. Students will learn what elements need to be considered to eliminate access barriers, and when they need to be addressed to prevent launch failures.

Erik Hefti, MSc, PhD, PharmD

Erik Hefti, MSc, PhD, PharmD

Program Director and Assistant Professor of Pharmaceutical Sciences at Harrisburg University and clinical pharmacist

The pharmaceutical industry represents an exciting, rewarding, and expanding opportunity for a myriad of different careers. Often, members of this business community are siloed in their traditional training, limiting communication ability with others at times. Programs like this Mini-MBA in Drug Commercialization & Product Strategy give students a multidisciplinary exposure to multiple aspects of the pharmaceutical industry, allowing for more professional communication and cooperation.

Mike Myers, MBA

Mike Myers, MBA

Adjunct Lecturer, Associate Director for the Center for Management Innovations in Healthcare, and Managing Director and a Founding Partner of CrowdPharm

This exciting program combines industry and academic expertise to provide professionals of all levels with the skills needed to fully understand pharma commercialization. From clinical development to regulatory and from finance to marketing, students will obtain the business and management insights and skills that are required to be successful in pharma both today and tomorrow.

Slade Smith, JD

Slade Smith, JD

Assistant Director of the Applied Health Policy Institute at the University of Arizona

A good businessperson must know the regulatory framework in which they operate. This course can help someone familiarize themselves with the regulations governing pharmaceutical companies by providing basic information about the structure of the law, the major regulatory actors, the aspects of business that are regulated, common terminology, and some history and background to allow the person to make sense of it all.

Tim Arendt

Tim Arendt

Managing Director for Syneos Health Consulting in Santa Monica, CA

The pharma/biotech space is an industry which generates significant contributions to the health and well-being of patients and caregivers in the U.S. and globally. It’s a complex industry which will require constant innovation and strategic thinking in order to maintain those contributions well into the future. With only a couple of formalized Master of Business Administration programs focusing on pharma/biotech, there is an inherent need for this program, and Eller Executive Education can take an academic leadership role in this dynamic industry.

What You Will Earn

Earn qualifications you can proudly show to the world: Upon graduation, you will receive a digital Mini-MBA in Drug Commercialization & Product Strategy certificate from Eller Executive Education which you can upload to your LinkedIn profile or add to your CV.

Tuition and Financing Options

Full Tuition

Pay in full

$6,995

upfront

Installments

Pay in 3 installments of

$2,335

contact us for details

About Eller Executive Education

Eller Executive Education is passionate about disrupting traditional executive education. By exploring the latest science in leadership development, modern business management theory, and contemporary learning design, they help organizations in over 93 global locations discover new ways to lead, manage, and innovate. Eller Executive Education is the fastest progressing executive education provider and holds a No. 5 ranking in the U.S. and No. 15 ranking globally for Customized Executive Education in the Financial Times Executive Education Ranking 2019.

As the non-degree leadership development arm of the University of Arizona's Eller College of Management, Eller Executive Education is connected to leading institutions that are internationally recognized for pioneering research, offering an innovative curriculum, working with distinguished faculty, their social responsibility, and their excellence in management information systems and entrepreneurship.

93

global locations have benefited from Eller Executive Education’s programs

25+

years of experience delivering executive education programs behind Eller Executive Education

Top 5

status has been maintained by Eller College of Management in the MIS undergraduate rankings by U.S. News & World Report since 1989 (the inception of the rankings)

#7

nationally for Public Online MBA Program (Eller College of Management, U.S. News & World Report, 2020)

#5

ranking in the U.S. and #15 ranking globally for Customized Executive Education Programs (Eller Executive Education, Financial Times 2019)

The cost of a two-year MBA program in the U.S. can be upwards of $100K. In contrast, our Mini-MBA in Drug Commercialization & Product Strategy offers an accelerated 12-week business program that walks you through the drug commercialization process from bench to bedside for the affordable price of $6,995. 

While MBA programs are often generalized, our Mini-MBA in Drug Commercialization & Product Strategy is geared specifically towards learners who want to gain a comprehensive understanding of the drug development and commercialization process from pre-launch, to launch, early in-market, growth, maturity, and end-of-patent life phases of a brand’s life cycle. It gives them a foundational knowledge of business strategy, market access, pharmaceutical science, pharma compliance/regulatory needs, marketing, market research, finance, and operations management in a pharma-specific context.

This certificate program was developed for professionals in the pharmaceutical industry or any other related industries who wish to develop a cross-disciplinary understanding of the drug development process and gain new leadership skills to accelerate growth in the business. 
That being said, we don’t recommend this program for pharmacy managers. If you’re interested in learning more about managing healthcare-related businesses, inquire about our 12-week Mini-MBA in Healthcare or our online MBA in Healthcare degree instead.

Yes, in fact the Mini-MBA in Drug Commercialization & Product Strategy was specifically designed to give candidates foundational knowledge in business, management, administration, and regulatory topics relating to the pharmaceutical industry. It’s also a great opportunity to formalize circumstantial knowledge which you have picked up along the way.

The cost for this 12-week program is $6,995. For this price, you will enjoy a facilitated learning experience and earn a Mini-MBA Certificate in Drug Commercialization & Product Strategy from Eller Executive Education.

There are no additional fees or costs whatsoever. There are no fees for application or graduation, and you do not have to pay for textbooks as all of the learning materials are featured online.

 

Take the Next Step

Inquire Now
Mini-MBA in Drug Commercialization & Product Strategy
Mini-MBA in Drug Commercialization & Product Strategy

By completing this form, you consent to our Terms & Conditions and Privacy Policy and you can unsubscribe at any time. By entering your mobile number you agree to receive notifications from OpusVi™ Updates short code 64317. Message and data rates may apply. You may receive alerts (up to 10 per month) until you choose to opt out of this service by texting 'Stop' to any of our messages. Text 'Help' to OpusVi™ Updates for assistance. Please view our mobile terms and conditions here.